Association Between Hypnotics, Accidents, and Injuries: A Study Based on the Adverse Drug Event Reporting Database in Japan

被引:0
|
作者
Sogawa, Rintaro [1 ]
Hatano, Masakazu [2 ]
Nishimura, Fumi [1 ]
Nishi, Junya [1 ]
Matsuoka, Ayaka [3 ]
Shinada, Kota [3 ]
Yamada, Haruna [4 ]
Tateishi, Hiroshi [5 ]
Mizoguchi, Yoshito [5 ]
Monji, Akira [6 ]
Shimanoe, Chisato [1 ]
机构
[1] Saga Univ Hosp, Dept Pharm, 5-1-1 Nabeshima, Saga 8498501, Japan
[2] Fujita Hlth Univ, Sch Med, Dept Pharmacotherapeut & Informat, Toyoake, Japan
[3] Saga Univ Hosp, Dept Emergency & Crit Care Med, Nabeshima, Japan
[4] Saga Univ, Inst Nursing, Fac Med, Nabeshima, Japan
[5] Saga Univ, Fac Med, Dept Psychiat, Nabeshima, Japan
[6] Wakahisa Hosp, Wakahisa, Japan
来源
IN VIVO | 2025年 / 39卷 / 01期
关键词
Accident; adverse drug event; hypnotics; injury; HIGHWAY DRIVING PERFORMANCE; ZOPICLONE; 7.5; MG; METAANALYSIS; MEDICATION; FALLS; RISK; PLACEBO;
D O I
10.21873/invivo.13846
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: The use of hypnotic drugs can lead to accidents and injuries. However, few reports have shown their association with these events after adjusting for many concomitant medications. This study aimed to determine whether the use of hypnotic drugs was associated with accidents and injuries. Patients and Methods: Using the Japanese Adverse Event Reporting Database, 772,387 reports published between September 2023 and April 2004 were analyzed. Reporting odds ratios (RORs) and 95% confidence intervals (CIs) for accidents and injuries associated with each hypnotic drug were calculated after adjusting for potential confounders. Results: Of the total, 12,484 reports indicated association of hypnotic drugs with accidents and injuries. The use of each hypnotic drug was associated with accidents, injuries, and other adverse events. However, a multivariate analysis adjusted for age, sex, reporting year, and concomitant medications showed a considerable decrease in ROR for melatonin receptor agonists (adjusted ROR=1.26; 95%CI=1.03-1.55) and dual orexin receptor antagonists (DORAs) (adjusted ROR=1.04; 95%CI=0.86-1.25). Particularly in DORAs, a loss of signal for accidents and injuries was observed. Conclusion: The risk of accidents and injuries may vary with hypnotic drug use; however, DORAs may be less frequently associated with these events. The results of this study provide useful information for the selection of hypnotic drugs.
引用
收藏
页码:433 / 439
页数:7
相关论文
共 50 条
  • [41] Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database
    Takuya Imatoh
    Kimie Sai
    Chisato Fukazawa
    Yasushi Hinomura
    Ryosuke Nakamura
    Yoshimi Okamoto-Uchida
    Katsunori Segawa
    Yoshiro Saito
    European Journal of Clinical Pharmacology, 2017, 73 : 1643 - 1653
  • [42] Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database
    Imatoh, Takuya
    Sai, Kimie
    Fukazawa, Chisato
    Hinomura, Yasushi
    Nakamura, Ryosuke
    Okamoto-Uchida, Yoshimi
    Segawa, Katsunori
    Saito, Yoshiro
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (12) : 1643 - 1653
  • [43] Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
    Noda, Aoi
    Sakai, Takamasa
    Tsuchiya, Masami
    Oyanagi, Gen
    Obara, Taku
    Mano, Nariyasu
    VACCINES, 2020, 8 (03) : 1 - 13
  • [44] Signal Detection of Adverse Drug Reaction of Amoxicillin Using the Korea Adverse Event Reporting System Database
    Soukavong, Mick
    Kim, Jungmee
    Park, Kyounghoon
    Yang, Bo Ram
    Lee, Joongyub
    Jin, Xue-Mei
    Park, Byung-Joo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2016, 31 (09) : 1355 - 1361
  • [45] A post-marketing pharmacovigilance study of avapritinib: Adverse event data mining and analysis based on the United States Food and Drug Administration Adverse Event Reporting System database
    Rong, Li
    Xie, Mengyuan
    Jiang, Manxue
    Qiu, Hongyu
    Kong, Lingti
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (08) : 1816 - 1826
  • [46] Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
    Toki T.
    Ono S.
    Drugs - Real World Outcomes, 2018, 5 (2) : 117 - 128
  • [47] Pharmacovigilance study of the association between peripheral neuropathy and antibody-drug conjugates using the FDA adverse event reporting system
    Chen, Yuheng
    Ren, Xiayang
    Dai, Yuanyuan
    Wang, Yanfeng
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [48] Novel Adverse Event of Atezolizumab: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Ahmed, Abdul Mannan Faruk
    Maheswari, Eswaran
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 306 - 306
  • [49] Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database
    Liu, Lulu
    Chen, Jia
    Wang, Lei
    Chen, Chen
    Chen, Li
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [50] Association between GvHD and nivolumab in the FDA adverse event reporting system
    Oshima, Y.
    Tanimoto, T.
    Yuji, K.
    Tojo, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (10) : 1463 - 1464